Heart Clinical Trials
Cedars-Sinai is consistently ranked as one of the best programs in the nation for cardiology and heart surgery by U.S. News & World Report. Cedars-Sinai continues to remain at the forefront of technology, innovation and discovery in heart care across the country and the world. As a patient, you'll have the opportunity to participate in clinical trials conducted by our cardiac specialists and researchers, all of whom are dedicated to advancing diagnostic and treatment options for the full range of heart conditions.
Questions? See the Clinical Trial FAQs.
- Atherosclerosis, Immune Mediated Inflammation & Hypoestrogenemia
- Early Feasibility Study for the Foldax Tria Aortic Heart Valve
- Effect of Evolocumab
- A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM
- Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
- A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) (MAVERICK-HCM)
- Safety and Potential Bioactivity of CLBS14 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
- Women's Heart Attack Research Program—Imaging Study (HARP)
- Bariatric Surgery & Heart Failure Study
- Basic Research Into Human Stem Cell Biology
- BIRI Study for Development & Validation of Novel MR-PET Imaging Techniques
- BSWHC Data and Specimen Repository Study
- CardiAMP™ Heart Failure Trial
- Cytokinetics (CK-3773274)
- Effect of Evolocumab
- EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study) (HFN-LIFE)
- Genetics of Cardiovascular Disease
- A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM
- Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
- Reducing Lung CongestIon Symptoms in Advanced Heart Failure (RELIEVE-HF)
- Risk Factors & Outcomes in Advanced Heart Disease
- Safety and Potential Bioactivity of CLBS14 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
- Smidt Heart Institute Takotsubo Registry
- Syncardia 70cc Temporary Total Artificial Heart Destination Therapy Study
- WISE CVD - Continuation (WISE HFpEF)
- Women's Heart Attack Research Program—Imaging Study (HARP)
- DCM Research Project: DCM-CMR Ancillary Study
- ATG
- BIRI Study for Development & Validation of Novel MR-PET Imaging Techniques
- BSWHC Data and Specimen Repository Study
- CAV
- Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- Effect of Evolocumab
- Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
- Prospective Survey Study
- Surveillance HeartCare® Outcomes Registry (SHORE)
- Tocilizumab in Cardiac Transplantation
- Women's Heart Attack Research Program—Imaging Study (HARP)
- Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
- BIRI Study for Development & Validation of Novel MR-PET Imaging Techniques
- Cardiac Imaging Research Registry
- Effect of Evolocumab
- Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology (PINNACLE FLX)
- Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia
- Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation (APOLLO)
- ACURATE IDE: Safety and Efficacy Study of Acurate Valve for Transcatheter Aortic Valve Replacement
- Assessment of Transcatheter and Surgical Aortic Bioprosthetic Valve Thrombosis and Its Treatment With Anticoagulation (RESOLVE)
- Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
- Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT)
- Evaluation of Transcatheter Aortic Valve Replacement Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis (EARLY TAVR)
- JenaValve Pericardial TAVR Aortic Regurgitation Study
- Multicenter Study of Congenital Pulmonic Valve Dysfunction Studying the SAPIEN 3 THV With the Alterra Adaptive Prestent (ALTERRA)
- Triluminate Pivotal Study
- TRISCEND II Pivotal Trial
- Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
- MISCEND Study
- REPAIR MR
- CSTN: PRIMARY
- Atherosclerosis, Immune Mediated Inflammation & Hypoestrogenemia
- Brain-Heart Connection in Takotsubo Cardiomyopathy
- BSWHC Data and Specimen Repository Study
- Cardiac MRI-Normal Reference Group Testing in Women
- Postpartum Cardiac Function
- Small Artery Heart Disease Clinical Trial
- Smidt Heart Institute Takotsubo Registry
- WISE CVD - Continuation (WISE HFpEF)
- Women's Heart Attack Research Program—Imaging Study (HARP)
- Women's Ischemia Trial (WARRIOR)
- Myocardial Steatosis in Women With CMD
- CLBS16 for Coronary Microvascular Dysfunction
- Amenorrhea Related Cardiovascular Health (ARCH)